FDA is announcing a public meeting to discuss proposed recommendations for the reauthorization of the Generic Drug User Fee Amendments for fiscal years 2028 through 2032.
Similar Posts
Fulijaya Manufacturing SDN. BHD. – 719172 – 01/14/2026
CGMP/Finished Pharmaceuticals/AdulteratedTown Food Service Equipment Co., Inc. Recalls Aluminum Saucepans Because of Possible Health Risk
Town Food Service Equipment Co., Inc. of Brooklyn, NY is recalling aluminum saucepans, because it has the potential to be contaminated with lead (Pb) which may leach into food. Lead is toxic to humans and can affect people of any age or health status, and there is no known safe level of exposure toUpdate on Alert: Defibrillation Lead Issue from Boston Scientific
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program.Disposable Surgical Stapler Cartridge Correction: Ethicon Endo-Surgery, LLC Issues Correction for Endopath Echelon to Address Inadvertent Lockout During Surgical Procedures
Ethicon Endo-Surgery is correcting the Endopath Echelon due to a potential surgical lockout that stops cutting or stapling and requires extra removal steps.FDA Roundup: July 14, 2023
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.Approved Drugs: Questions and Answers
How is a medicine approved by FDA?, How can I find out if my medicine is approved by FDA?